nodes	percent_of_prediction	percent_of_DWPC	metapath
Thalidomide—TNF—leprosy	0.473	1	CbGaD
Thalidomide—PTGS2—Dapsone—leprosy	0.0663	0.153	CbGbCtD
Thalidomide—PTGS1—Dapsone—leprosy	0.056	0.129	CbGbCtD
Thalidomide—CYP2E1—Rifampicin—leprosy	0.0524	0.121	CbGbCtD
Thalidomide—CYP2E1—Dapsone—leprosy	0.0433	0.1	CbGbCtD
Thalidomide—CYP3A5—Rifampicin—leprosy	0.0407	0.0941	CbGbCtD
Thalidomide—CYP3A5—Dapsone—leprosy	0.0336	0.0777	CbGbCtD
Thalidomide—CYP2C19—Rifampicin—leprosy	0.0328	0.0759	CbGbCtD
Thalidomide—CYP1A2—Rifampicin—leprosy	0.0303	0.0701	CbGbCtD
Thalidomide—CYP2C9—Rifampicin—leprosy	0.0273	0.0631	CbGbCtD
Thalidomide—CYP2C19—Dapsone—leprosy	0.0271	0.0627	CbGbCtD
Thalidomide—CYP2C9—Dapsone—leprosy	0.0225	0.0521	CbGbCtD
Thalidomide—Pomalidomide—TNF—leprosy	0.00328	1	CrCbGaD
Thalidomide—FGFR2—skin epidermis—leprosy	0.00265	0.146	CbGeAlD
Thalidomide—NFKB1—Canonical NF-kappaB pathway—CYLD—leprosy	0.00186	0.0253	CbGpPWpGaD
Thalidomide—TNF—IL23-mediated signaling events—IL23R—leprosy	0.00177	0.0241	CbGpPWpGaD
Thalidomide—NFKB1—p75NTR signals via NF-kB—RIPK2—leprosy	0.0016	0.0218	CbGpPWpGaD
Thalidomide—TNF—Canonical NF-kappaB pathway—CYLD—leprosy	0.00141	0.0193	CbGpPWpGaD
Thalidomide—NFKB1—eye—leprosy	0.00126	0.0694	CbGeAlD
Thalidomide—NFKB1—Canonical NF-kappaB pathway—RIPK2—leprosy	0.0012	0.0163	CbGpPWpGaD
Thalidomide—NFKB1—IL1 and megakaryotyces in obesity—TLR2—leprosy	0.00116	0.0158	CbGpPWpGaD
Thalidomide—PTGS2—hindlimb—leprosy	0.00113	0.0623	CbGeAlD
Thalidomide—NFKB1—Canonical NF-kappaB pathway—NOD2—leprosy	0.00108	0.0148	CbGpPWpGaD
Thalidomide—NFKB1—TAK1 activates NFkB by phosphorylation and activation of IKKs complex—RIPK2—leprosy	0.00108	0.0148	CbGpPWpGaD
Thalidomide—NFKB1—TNF receptor signaling pathway —CYLD—leprosy	0.00107	0.0145	CbGpPWpGaD
Thalidomide—NFKB1—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—CYLD—leprosy	0.000998	0.0136	CbGpPWpGaD
Thalidomide—NFKB1—TAK1 activates NFkB by phosphorylation and activation of IKKs complex—NOD2—leprosy	0.000983	0.0134	CbGpPWpGaD
Thalidomide—PTGS2—appendage—leprosy	0.000969	0.0535	CbGeAlD
Thalidomide—CYP1A1—skin epidermis—leprosy	0.00096	0.053	CbGeAlD
Thalidomide—FGFR2—eye—leprosy	0.000944	0.0521	CbGeAlD
Thalidomide—NFKB1—Apoptosis—LTA—leprosy	0.000935	0.0128	CbGpPWpGaD
Thalidomide—TNF—Canonical NF-kappaB pathway—RIPK2—leprosy	0.000912	0.0124	CbGpPWpGaD
Thalidomide—NFKB1—tendon—leprosy	0.000833	0.046	CbGeAlD
Thalidomide—TNF—Canonical NF-kappaB pathway—NOD2—leprosy	0.000827	0.0113	CbGpPWpGaD
Thalidomide—FGFR2—skin of body—leprosy	0.000822	0.0453	CbGeAlD
Thalidomide—TNF—TNF receptor signaling pathway —CYLD—leprosy	0.000813	0.0111	CbGpPWpGaD
Thalidomide—PTGS2—skin epidermis—leprosy	0.000806	0.0445	CbGeAlD
Thalidomide—NFKB1—Interleukin-1 signaling—RIPK2—leprosy	0.000769	0.0105	CbGpPWpGaD
Thalidomide—NFKB1—Downstream TCR signaling—RIPK2—leprosy	0.000754	0.0103	CbGpPWpGaD
Thalidomide—NFKB1—T-Cell Receptor and Co-stimulatory Signaling—CD8A—leprosy	0.000753	0.0103	CbGpPWpGaD
Thalidomide—NFKB1—Toll-like Receptor Signaling Pathway—TLR1—leprosy	0.000714	0.00973	CbGpPWpGaD
Thalidomide—TNF—Apoptosis—LTA—leprosy	0.000712	0.00971	CbGpPWpGaD
Thalidomide—CRBN—tendon—leprosy	0.000698	0.0385	CbGeAlD
Thalidomide—NFKB1—Interleukin-1 signaling—NOD2—leprosy	0.000697	0.0095	CbGpPWpGaD
Thalidomide—NFKB1—testis—leprosy	0.000689	0.0381	CbGeAlD
Thalidomide—NFKB1—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—CYLD—leprosy	0.000685	0.00934	CbGpPWpGaD
Thalidomide—NFKB1—nervous system—leprosy	0.000677	0.0373	CbGeAlD
Thalidomide—NFKB1—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—RIPK2—leprosy	0.000643	0.00877	CbGpPWpGaD
Thalidomide—NFKB1—CD40/CD40L signaling—CD40LG—leprosy	0.000641	0.00874	CbGpPWpGaD
Thalidomide—TNF—Cytokines and Inflammatory Response—IL10—leprosy	0.000615	0.00838	CbGpPWpGaD
Thalidomide—NFKB1—Apoptosis-related network due to altered Notch3 in ovarian cancer—RIPK2—leprosy	0.000614	0.00837	CbGpPWpGaD
Thalidomide—NFKB1—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—NOD2—leprosy	0.000583	0.00795	CbGpPWpGaD
Thalidomide—CRBN—testis—leprosy	0.000578	0.0319	CbGeAlD
Thalidomide—CRBN—nervous system—leprosy	0.000567	0.0313	CbGeAlD
Thalidomide—PTGS1—blood vessel—leprosy	0.000564	0.0311	CbGeAlD
Thalidomide—NFKB1—TCR signaling—RIPK2—leprosy	0.000563	0.00768	CbGpPWpGaD
Thalidomide—TNF—FAS pathway and Stress induction of HSP regulation—RIPK2—leprosy	0.000563	0.00768	CbGpPWpGaD
Thalidomide—NFKB1—Regulation of toll-like receptor signaling pathway—TLR1—leprosy	0.000557	0.0076	CbGpPWpGaD
Thalidomide—NFKB1—IL12-mediated signaling events—RIPK2—leprosy	0.000556	0.00758	CbGpPWpGaD
Thalidomide—TNF—Toll-like Receptor Signaling Pathway—TLR1—leprosy	0.000544	0.00741	CbGpPWpGaD
Thalidomide—PTGS2—blood vessel—leprosy	0.000539	0.0298	CbGeAlD
Thalidomide—NFKB1—IL1 and megakaryotyces in obesity—IFNG—leprosy	0.000521	0.00711	CbGpPWpGaD
Thalidomide—FGFR2—testis—leprosy	0.000518	0.0286	CbGeAlD
Thalidomide—FGFR2—nervous system—leprosy	0.000508	0.028	CbGeAlD
Thalidomide—TNF—Cytokines and Inflammatory Response—HLA-DRB1—leprosy	0.000495	0.00675	CbGpPWpGaD
Thalidomide—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—RIPK2—leprosy	0.000468	0.00638	CbGpPWpGaD
Thalidomide—NFKB1—Downstream TCR signaling—HLA-DRB1—leprosy	0.000465	0.00634	CbGpPWpGaD
Thalidomide—NFKB1—TRAF6 Mediated Induction of proinflammatory cytokines—RIPK2—leprosy	0.000465	0.00634	CbGpPWpGaD
Thalidomide—NFKB1—Regulation of toll-like receptor signaling pathway—CYLD—leprosy	0.00044	0.006	CbGpPWpGaD
Thalidomide—NFKB1—p75 NTR receptor-mediated signalling—RIPK2—leprosy	0.000433	0.0059	CbGpPWpGaD
Thalidomide—TNF—Regulation of toll-like receptor signaling pathway—TLR1—leprosy	0.000424	0.00579	CbGpPWpGaD
Thalidomide—NFKB1—TRAF6 Mediated Induction of proinflammatory cytokines—NOD2—leprosy	0.000421	0.00575	CbGpPWpGaD
Thalidomide—NFKB1—IL12-mediated signaling events—CD8A—leprosy	0.000421	0.00574	CbGpPWpGaD
Thalidomide—NFKB1—MyD88 cascade initiated on plasma membrane—RIPK2—leprosy	0.000421	0.00573	CbGpPWpGaD
Thalidomide—NFKB1—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—RIPK2—leprosy	0.000417	0.00568	CbGpPWpGaD
Thalidomide—NFKB1—MyD88 dependent cascade initiated on endosome—RIPK2—leprosy	0.000409	0.00558	CbGpPWpGaD
Thalidomide—NFKB1—TCR Signaling Pathway—RIPK2—leprosy	0.000402	0.00548	CbGpPWpGaD
Thalidomide—NFKB1—T-Cell Receptor and Co-stimulatory Signaling—IL2—leprosy	0.000398	0.00543	CbGpPWpGaD
Thalidomide—NFKB1—Toll Like Receptor 9 (TLR9) Cascade—RIPK2—leprosy	0.000395	0.00538	CbGpPWpGaD
Thalidomide—NFKB1—MyD88:Mal cascade initiated on plasma membrane—RIPK2—leprosy	0.000388	0.00529	CbGpPWpGaD
Thalidomide—NFKB1—MyD88:Mal cascade initiated on plasma membrane—TLR2—leprosy	0.000388	0.00529	CbGpPWpGaD
Thalidomide—NFKB1—MyD88 cascade initiated on plasma membrane—NOD2—leprosy	0.000381	0.0052	CbGpPWpGaD
Thalidomide—NFKB1—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NOD2—leprosy	0.000378	0.00515	CbGpPWpGaD
Thalidomide—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—leprosy	0.000375	0.00512	CbGpPWpGaD
Thalidomide—TNF—IL27-mediated signaling events—IFNG—leprosy	0.000372	0.00508	CbGpPWpGaD
Thalidomide—NFKB1—MyD88-independent cascade—RIPK2—leprosy	0.000372	0.00508	CbGpPWpGaD
Thalidomide—NFKB1—MyD88 dependent cascade initiated on endosome—NOD2—leprosy	0.000371	0.00506	CbGpPWpGaD
Thalidomide—NFKB1—IL23-mediated signaling events—IFNG—leprosy	0.000369	0.00503	CbGpPWpGaD
Thalidomide—NFKB1—Toll-like Receptor Signaling Pathway—TLR2—leprosy	0.000363	0.00496	CbGpPWpGaD
Thalidomide—TNF—Cytokines and Inflammatory Response—IFNG—leprosy	0.000361	0.00493	CbGpPWpGaD
Thalidomide—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—leprosy	0.000359	0.0049	CbGpPWpGaD
Thalidomide—NFKB1—Toll Like Receptor 9 (TLR9) Cascade—NOD2—leprosy	0.000358	0.00488	CbGpPWpGaD
Thalidomide—NFKB1—IL23-mediated signaling events—CD4—leprosy	0.000356	0.00486	CbGpPWpGaD
Thalidomide—NFKB1—MyD88:Mal cascade initiated on plasma membrane—NOD2—leprosy	0.000352	0.0048	CbGpPWpGaD
Thalidomide—TNF—Cytokines and Inflammatory Response—CD4—leprosy	0.000349	0.00476	CbGpPWpGaD
Thalidomide—NFKB1—Canonical NF-kappaB pathway—TNF—leprosy	0.000349	0.00476	CbGpPWpGaD
Thalidomide—NFKB1—EBV LMP1 signaling—TNF—leprosy	0.000349	0.00476	CbGpPWpGaD
Thalidomide—NFKB1—TCR signaling—HLA-DRB1—leprosy	0.000348	0.00474	CbGpPWpGaD
Thalidomide—NFKB1—Signaling by Interleukins—RIPK2—leprosy	0.000347	0.00473	CbGpPWpGaD
Thalidomide—NFKB1—IL12-mediated signaling events—HLA-DRB1—leprosy	0.000343	0.00468	CbGpPWpGaD
Thalidomide—NFKB1—MyD88-independent cascade—NOD2—leprosy	0.000337	0.0046	CbGpPWpGaD
Thalidomide—TNF—Regulation of toll-like receptor signaling pathway—CYLD—leprosy	0.000335	0.00457	CbGpPWpGaD
Thalidomide—NFKB1—Activated TLR4 signalling—RIPK2—leprosy	0.000335	0.00457	CbGpPWpGaD
Thalidomide—NFKB1—Activated TLR4 signalling—TLR2—leprosy	0.000335	0.00457	CbGpPWpGaD
Thalidomide—TNF—IL27-mediated signaling events—IL2—leprosy	0.000331	0.00451	CbGpPWpGaD
Thalidomide—NFKB1—Downstream TCR signaling—CD4—leprosy	0.000328	0.00447	CbGpPWpGaD
Thalidomide—NFKB1—IL23-mediated signaling events—IL2—leprosy	0.000328	0.00447	CbGpPWpGaD
Thalidomide—NFKB1—IL2 signaling events mediated by PI3K—IL2—leprosy	0.000328	0.00447	CbGpPWpGaD
Thalidomide—TNF—Cytokines and Inflammatory Response—IL2—leprosy	0.000321	0.00438	CbGpPWpGaD
Thalidomide—NFKB1—Toll Like Receptor 4 (TLR4) Cascade—RIPK2—leprosy	0.000315	0.00429	CbGpPWpGaD
Thalidomide—NFKB1—Toll Like Receptor 4 (TLR4) Cascade—TLR2—leprosy	0.000315	0.00429	CbGpPWpGaD
Thalidomide—NFKB1—Signaling by Interleukins—NOD2—leprosy	0.000315	0.00429	CbGpPWpGaD
Thalidomide—NFKB1—TCR Signaling Pathway—CD8A—leprosy	0.000304	0.00415	CbGpPWpGaD
Thalidomide—NFKB1—Activated TLR4 signalling—NOD2—leprosy	0.000304	0.00414	CbGpPWpGaD
Thalidomide—CYP1A1—skin of body—leprosy	0.000297	0.0164	CbGeAlD
Thalidomide—TNF—Downstream signaling in naïve CD8+ T cells—CD8A—leprosy	0.000297	0.00405	CbGpPWpGaD
Thalidomide—NFKB1—Toll Like Receptor 4 (TLR4) Cascade—NOD2—leprosy	0.000286	0.00389	CbGpPWpGaD
Thalidomide—NFKB1—Vitamin B12 Metabolism—IFNG—leprosy	0.000285	0.00389	CbGpPWpGaD
Thalidomide—NFKB1—Regulation of toll-like receptor signaling pathway—TLR2—leprosy	0.000284	0.00387	CbGpPWpGaD
Thalidomide—TNF—IL23-mediated signaling events—IFNG—leprosy	0.000281	0.00383	CbGpPWpGaD
Thalidomide—NFKB1—Toll-Like Receptors Cascades—RIPK2—leprosy	0.000281	0.00383	CbGpPWpGaD
Thalidomide—NFKB1—Toll-Like Receptors Cascades—TLR2—leprosy	0.000281	0.00383	CbGpPWpGaD
Thalidomide—TNF—Toll-like Receptor Signaling Pathway—TLR2—leprosy	0.000277	0.00378	CbGpPWpGaD
Thalidomide—NFKB1—TGF-beta Receptor Signaling—IFNG—leprosy	0.000272	0.00372	CbGpPWpGaD
Thalidomide—TNF—IL23-mediated signaling events—CD4—leprosy	0.000271	0.0037	CbGpPWpGaD
Thalidomide—NFKB1—amb2 Integrin signaling—TNF—leprosy	0.000268	0.00365	CbGpPWpGaD
Thalidomide—NFKB1—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—leprosy	0.000261	0.00357	CbGpPWpGaD
Thalidomide—PTGS1—skin of body—leprosy	0.000261	0.0144	CbGeAlD
Thalidomide—TNF—Allograft Rejection—IL10—leprosy	0.00026	0.00355	CbGpPWpGaD
Thalidomide—TNF—Allograft Rejection—CD40LG—leprosy	0.00026	0.00355	CbGpPWpGaD
Thalidomide—NFKB1—Toll-Like Receptors Cascades—NOD2—leprosy	0.000254	0.00347	CbGpPWpGaD
Thalidomide—NFKB1—IL12-mediated signaling events—IFNG—leprosy	0.00025	0.00342	CbGpPWpGaD
Thalidomide—PTGS2—skin of body—leprosy	0.00025	0.0138	CbGeAlD
Thalidomide—TNF—IL23-mediated signaling events—IL2—leprosy	0.00025	0.0034	CbGpPWpGaD
Thalidomide—NFKB1—TCR signaling—CD4—leprosy	0.000245	0.00334	CbGpPWpGaD
Thalidomide—NFKB1—IL12-mediated signaling events—CD4—leprosy	0.000242	0.0033	CbGpPWpGaD
Thalidomide—PTGS1—Overview of nanoparticle effects—TNF—leprosy	0.000241	0.00329	CbGpPWpGaD
Thalidomide—NFKB1—IL23-mediated signaling events—TNF—leprosy	0.000239	0.00325	CbGpPWpGaD
Thalidomide—TNF—Aryl Hydrocarbon Receptor Pathway—IFNG—leprosy	0.000236	0.00322	CbGpPWpGaD
Thalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—leprosy	0.000232	0.00317	CbGpPWpGaD
Thalidomide—NFKB1—Folate Metabolism—IFNG—leprosy	0.000232	0.00316	CbGpPWpGaD
Thalidomide—NFKB1—Regulation of Telomerase—IFNG—leprosy	0.000227	0.00309	CbGpPWpGaD
Thalidomide—NFKB1—IL12-mediated signaling events—IL2—leprosy	0.000223	0.00303	CbGpPWpGaD
Thalidomide—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—leprosy	0.000221	0.00301	CbGpPWpGaD
Thalidomide—TNF—Vitamin B12 Metabolism—IFNG—leprosy	0.000217	0.00296	CbGpPWpGaD
Thalidomide—TNF—Regulation of toll-like receptor signaling pathway—TLR2—leprosy	0.000216	0.00295	CbGpPWpGaD
Thalidomide—NFKB1—TWEAK Signaling Pathway—TNF—leprosy	0.000216	0.00294	CbGpPWpGaD
Thalidomide—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—leprosy	0.000211	0.00288	CbGpPWpGaD
Thalidomide—TNF—Aryl Hydrocarbon Receptor Pathway—IL2—leprosy	0.00021	0.00286	CbGpPWpGaD
Thalidomide—TNF—Allograft Rejection—HLA-DRB1—leprosy	0.00021	0.00286	CbGpPWpGaD
Thalidomide—TNF—TGF-beta Receptor Signaling—IFNG—leprosy	0.000208	0.00283	CbGpPWpGaD
Thalidomide—CYP2E1—tendon—leprosy	0.000206	0.0114	CbGeAlD
Thalidomide—NFKB1—Folate Metabolism—IL2—leprosy	0.000206	0.00281	CbGpPWpGaD
Thalidomide—NFKB1—Regulation of Telomerase—IL2—leprosy	0.000201	0.00275	CbGpPWpGaD
Thalidomide—NFKB1—Aryl Hydrocarbon Receptor—TNF—leprosy	0.0002	0.00273	CbGpPWpGaD
Thalidomide—NFKB1—TNF receptor signaling pathway —TNF—leprosy	0.0002	0.00273	CbGpPWpGaD
Thalidomide—PTGS1—tendon—leprosy	0.000199	0.011	CbGeAlD
Thalidomide—NFKB1—SIDS Susceptibility Pathways—IL10—leprosy	0.000198	0.0027	CbGpPWpGaD
Thalidomide—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—leprosy	0.000196	0.00268	CbGpPWpGaD
Thalidomide—NFKB1—Glucocorticoid receptor regulatory network—IFNG—leprosy	0.000195	0.00266	CbGpPWpGaD
Thalidomide—NFKB1—Ceramide signaling pathway—TNF—leprosy	0.000194	0.00264	CbGpPWpGaD
Thalidomide—PTGS2—Overview of nanoparticle effects—TNF—leprosy	0.000192	0.00261	CbGpPWpGaD
Thalidomide—PTGS2—tendon—leprosy	0.00019	0.0105	CbGeAlD
Thalidomide—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—leprosy	0.000188	0.00256	CbGpPWpGaD
Thalidomide—NFKB1—Angiopoietin receptor Tie2-mediated signaling—TNF—leprosy	0.000188	0.00256	CbGpPWpGaD
Thalidomide—NFKB1—Vitamin B12 Metabolism—TNF—leprosy	0.000185	0.00252	CbGpPWpGaD
Thalidomide—NFKB1—Selenium Micronutrient Network—IFNG—leprosy	0.000184	0.00251	CbGpPWpGaD
Thalidomide—CYP1A1—nervous system—leprosy	0.000184	0.0102	CbGeAlD
Thalidomide—NFKB1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—leprosy	0.000179	0.00244	CbGpPWpGaD
Thalidomide—TNF—Folate Metabolism—IFNG—leprosy	0.000177	0.00241	CbGpPWpGaD
Thalidomide—TNF—Downstream signaling in naïve CD8+ T cells—IFNG—leprosy	0.000177	0.00241	CbGpPWpGaD
Thalidomide—NFKB1—TGF-beta Receptor Signaling—TNF—leprosy	0.000176	0.0024	CbGpPWpGaD
Thalidomide—NFKB1—TCR Signaling Pathway—CD4—leprosy	0.000175	0.00238	CbGpPWpGaD
Thalidomide—NFKB1—Cardiac Hypertrophic Response—TNF—leprosy	0.000174	0.00237	CbGpPWpGaD
Thalidomide—NFKB1—Glucocorticoid receptor regulatory network—IL2—leprosy	0.000173	0.00236	CbGpPWpGaD
Thalidomide—CYP2E1—testis—leprosy	0.000171	0.00943	CbGeAlD
Thalidomide—CYP2E1—nervous system—leprosy	0.000168	0.00926	CbGeAlD
Thalidomide—FGFR2—Cardiac Hypertrophic Response—TNF—leprosy	0.000165	0.00225	CbGpPWpGaD
Thalidomide—PTGS1—testis—leprosy	0.000165	0.00909	CbGeAlD
Thalidomide—NFKB1—Cytokine Signaling in Immune system—RIPK2—leprosy	0.000162	0.00221	CbGpPWpGaD
Thalidomide—PTGS1—nervous system—leprosy	0.000162	0.00892	CbGeAlD
Thalidomide—NFKB1—Signaling by NGF—RIPK2—leprosy	0.000159	0.00217	CbGpPWpGaD
Thalidomide—NFKB1—Corticotropin-releasing hormone—IL2—leprosy	0.000158	0.00216	CbGpPWpGaD
Thalidomide—TNF—Downstream signaling in naïve CD8+ T cells—IL2—leprosy	0.000157	0.00214	CbGpPWpGaD
Thalidomide—TNF—Folate Metabolism—IL2—leprosy	0.000157	0.00214	CbGpPWpGaD
Thalidomide—PTGS2—nervous system—leprosy	0.000154	0.00852	CbGeAlD
Thalidomide—TNF—Allograft Rejection—IFNG—leprosy	0.000153	0.00209	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by NGF—RIPK2—leprosy	0.000151	0.00206	CbGpPWpGaD
Thalidomide—TNF—SIDS Susceptibility Pathways—IL10—leprosy	0.000151	0.00206	CbGpPWpGaD
Thalidomide—NFKB1—Folate Metabolism—TNF—leprosy	0.00015	0.00205	CbGpPWpGaD
Thalidomide—NFKB1—Cytokine Signaling in Immune system—NOD2—leprosy	0.000147	0.002	CbGpPWpGaD
Thalidomide—NFKB1—Signaling events mediated by HDAC Class I—TNF—leprosy	0.000143	0.00195	CbGpPWpGaD
Thalidomide—NFKB1—Innate Immune System—CYLD—leprosy	0.000141	0.00192	CbGpPWpGaD
Thalidomide—TNF—Selenium Micronutrient Network—IFNG—leprosy	0.00014	0.00192	CbGpPWpGaD
Thalidomide—NFKB1—Signaling by Interleukins—IL2—leprosy	0.000139	0.0019	CbGpPWpGaD
Thalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—leprosy	0.000137	0.00186	CbGpPWpGaD
Thalidomide—TNF—Allograft Rejection—IL2—leprosy	0.000136	0.00186	CbGpPWpGaD
Thalidomide—FGFR2—Innate Immune System—CYLD—leprosy	0.000134	0.00182	CbGpPWpGaD
Thalidomide—NFKB1—Transcriptional regulation of white adipocyte differentiation—TNF—leprosy	0.000133	0.00181	CbGpPWpGaD
Thalidomide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—leprosy	0.00013	0.00177	CbGpPWpGaD
Thalidomide—NFKB1—Apoptosis—TNF—leprosy	0.000124	0.00169	CbGpPWpGaD
Thalidomide—NFKB1—MicroRNAs in cardiomyocyte hypertrophy—TNF—leprosy	0.000124	0.00169	CbGpPWpGaD
Thalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—leprosy	0.000121	0.00165	CbGpPWpGaD
Thalidomide—NFKB1—Adaptive Immune System—PARK2—leprosy	0.00012	0.00163	CbGpPWpGaD
Thalidomide—NFKB1—Selenium Micronutrient Network—TNF—leprosy	0.000119	0.00163	CbGpPWpGaD
Thalidomide—FGFR2—MicroRNAs in cardiomyocyte hypertrophy—TNF—leprosy	0.000117	0.0016	CbGpPWpGaD
Thalidomide—NFKB1—TNF alpha Signaling Pathway—TNF—leprosy	0.000115	0.00157	CbGpPWpGaD
Thalidomide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—leprosy	0.000115	0.00157	CbGpPWpGaD
Thalidomide—FGFR2—Adaptive Immune System—PARK2—leprosy	0.000114	0.00155	CbGpPWpGaD
Thalidomide—TNF—Spinal Cord Injury—IFNG—leprosy	0.000111	0.00151	CbGpPWpGaD
Thalidomide—PTGS1—Selenium Micronutrient Network—IFNG—leprosy	0.000109	0.00149	CbGpPWpGaD
Thalidomide—NFKB1—Toll-like Receptor Signaling Pathway—TNF—leprosy	0.000106	0.00145	CbGpPWpGaD
Thalidomide—NFKB1—Cytokine Signaling in Immune system—HLA-DRB1—leprosy	0.0001	0.00136	CbGpPWpGaD
Thalidomide—TNF—Spinal Cord Injury—IL2—leprosy	9.87e-05	0.00135	CbGpPWpGaD
Thalidomide—PTGS2—Aryl Hydrocarbon Receptor—TNF—leprosy	9.45e-05	0.00129	CbGpPWpGaD
Thalidomide—NFKB1—Innate Immune System—RIPK2—leprosy	9.09e-05	0.00124	CbGpPWpGaD
Thalidomide—NFKB1—Innate Immune System—TLR2—leprosy	9.09e-05	0.00124	CbGpPWpGaD
Thalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—leprosy	8.84e-05	0.00121	CbGpPWpGaD
Thalidomide—NFKB1—Adaptive Immune System—RIPK2—leprosy	8.73e-05	0.00119	CbGpPWpGaD
Thalidomide—PTGS2—C-MYB transcription factor network—CD4—leprosy	8.71e-05	0.00119	CbGpPWpGaD
Thalidomide—PTGS2—Selenium Micronutrient Network—IFNG—leprosy	8.69e-05	0.00118	CbGpPWpGaD
Thalidomide—FGFR2—Innate Immune System—TLR2—leprosy	8.62e-05	0.00118	CbGpPWpGaD
Thalidomide—FGFR2—Innate Immune System—RIPK2—leprosy	8.62e-05	0.00118	CbGpPWpGaD
Thalidomide—CYP1A1—Aryl Hydrocarbon Receptor—TNF—leprosy	8.38e-05	0.00114	CbGpPWpGaD
Thalidomide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—leprosy	8.38e-05	0.00114	CbGpPWpGaD
Thalidomide—FGFR2—Adaptive Immune System—RIPK2—leprosy	8.28e-05	0.00113	CbGpPWpGaD
Thalidomide—NFKB1—Regulation of toll-like receptor signaling pathway—TNF—leprosy	8.28e-05	0.00113	CbGpPWpGaD
Thalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—leprosy	8.26e-05	0.00113	CbGpPWpGaD
Thalidomide—NFKB1—Innate Immune System—NOD2—leprosy	8.24e-05	0.00112	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—CYLD—leprosy	8.21e-05	0.00112	CbGpPWpGaD
Thalidomide—FGFR2—Innate Immune System—NOD2—leprosy	7.82e-05	0.00107	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—CYLD—leprosy	7.79e-05	0.00106	CbGpPWpGaD
Thalidomide—NFKB1—SIDS Susceptibility Pathways—TNF—leprosy	7.55e-05	0.00103	CbGpPWpGaD
Thalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—leprosy	7.34e-05	0.001	CbGpPWpGaD
Thalidomide—NFKB1—Cytokine Signaling in Immune system—IFNG—leprosy	7.3e-05	0.000996	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—PARK2—leprosy	7.26e-05	0.00099	CbGpPWpGaD
Thalidomide—NFKB1—MAPK Signaling Pathway—TNF—leprosy	7.11e-05	0.00097	CbGpPWpGaD
Thalidomide—PTGS1—Selenium Micronutrient Network—TNF—leprosy	7.08e-05	0.000966	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—PARK2—leprosy	6.89e-05	0.000939	CbGpPWpGaD
Thalidomide—PTGS2—Spinal Cord Injury—IFNG—leprosy	6.87e-05	0.000937	CbGpPWpGaD
Thalidomide—NFKB1—Adaptive Immune System—CD40LG—leprosy	6.69e-05	0.000912	CbGpPWpGaD
Thalidomide—NFKB1—Adaptive Immune System—CD8A—leprosy	6.61e-05	0.000902	CbGpPWpGaD
Thalidomide—NFKB1—Cytokine Signaling in Immune system—IL2—leprosy	6.49e-05	0.000885	CbGpPWpGaD
Thalidomide—NFKB1—Integrated Pancreatic Cancer Pathway—TNF—leprosy	6.42e-05	0.000875	CbGpPWpGaD
Thalidomide—FGFR2—Disease—SLC11A1—leprosy	6.36e-05	0.000867	CbGpPWpGaD
Thalidomide—FGFR2—Adaptive Immune System—CD40LG—leprosy	6.35e-05	0.000865	CbGpPWpGaD
Thalidomide—FGFR2—Adaptive Immune System—CD8A—leprosy	6.27e-05	0.000856	CbGpPWpGaD
Thalidomide—PTGS2—Spinal Cord Injury—IL2—leprosy	6.1e-05	0.000832	CbGpPWpGaD
Thalidomide—PTGS2—Selenium Micronutrient Network—TNF—leprosy	5.62e-05	0.000767	CbGpPWpGaD
Thalidomide—NFKB1—Adaptive Immune System—HLA-DRB1—leprosy	5.38e-05	0.000734	CbGpPWpGaD
Thalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—leprosy	5.35e-05	0.000729	CbGpPWpGaD
Thalidomide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—leprosy	5.35e-05	0.000729	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—RIPK2—leprosy	5.29e-05	0.000722	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—TLR2—leprosy	5.29e-05	0.000722	CbGpPWpGaD
Thalidomide—FGFR2—Adaptive Immune System—HLA-DRB1—leprosy	5.11e-05	0.000697	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—RIPK2—leprosy	5.02e-05	0.000685	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—TLR2—leprosy	5.02e-05	0.000685	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—NOD2—leprosy	4.8e-05	0.000654	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—NOD2—leprosy	4.55e-05	0.000621	CbGpPWpGaD
Thalidomide—PTGS2—Spinal Cord Injury—TNF—leprosy	4.45e-05	0.000606	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—SDHD—leprosy	4.43e-05	0.000604	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—CD40LG—leprosy	4.06e-05	0.000553	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—CD8A—leprosy	4.01e-05	0.000547	CbGpPWpGaD
Thalidomide—NFKB1—Innate Immune System—CD4—leprosy	3.96e-05	0.000539	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—CD40LG—leprosy	3.85e-05	0.000525	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—CD8A—leprosy	3.81e-05	0.000519	CbGpPWpGaD
Thalidomide—NFKB1—Adaptive Immune System—CD4—leprosy	3.8e-05	0.000518	CbGpPWpGaD
Thalidomide—FGFR2—Innate Immune System—CD4—leprosy	3.75e-05	0.000512	CbGpPWpGaD
Thalidomide—FGFR2—Adaptive Immune System—CD4—leprosy	3.6e-05	0.000491	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—SDHD—leprosy	3.52e-05	0.00048	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—RIPK2—leprosy	3.42e-05	0.000467	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—SDHD—leprosy	3.31e-05	0.000452	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—SDHD—leprosy	3.31e-05	0.000451	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—HLA-DRB1—leprosy	3.27e-05	0.000445	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—RIPK2—leprosy	3.25e-05	0.000443	CbGpPWpGaD
Thalidomide—PTGS2—Disease—SLC11A1—leprosy	3.16e-05	0.000431	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—SDHD—leprosy	3.12e-05	0.000426	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—HLA-DRB1—leprosy	3.1e-05	0.000423	CbGpPWpGaD
Thalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—leprosy	3.02e-05	0.000412	CbGpPWpGaD
Thalidomide—NFKB1—Developmental Biology—TNF—leprosy	3e-05	0.000409	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—SDHD—leprosy	2.56e-05	0.000349	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—IFNG—leprosy	2.39e-05	0.000325	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—SDHD—leprosy	2.33e-05	0.000318	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—CD4—leprosy	2.3e-05	0.000314	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—IFNG—leprosy	2.26e-05	0.000309	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—CD4—leprosy	2.19e-05	0.000298	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—IL2—leprosy	2.12e-05	0.000289	CbGpPWpGaD
Thalidomide—FGFR2—Disease—CD4—leprosy	2.02e-05	0.000275	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—IL2—leprosy	2.01e-05	0.000274	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—SDHD—leprosy	1.99e-05	0.000272	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—IL2—leprosy	1.37e-05	0.000187	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—IL2—leprosy	1.3e-05	0.000177	CbGpPWpGaD
Thalidomide—PTGS2—Disease—CD4—leprosy	1e-05	0.000137	CbGpPWpGaD
